These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 27373480)
1. [Survival analysis of surgically treated renal cell carcinoma: an analysis of 10-year data from single center]. Zhang YS; Yu HY; Dong F; Li HZ Zhonghua Wai Ke Za Zhi; 2016 Jul; 54(7):528-33. PubMed ID: 27373480 [TBL] [Abstract][Full Text] [Related]
2. Survival analysis of surgically treated renal cell carcinoma: a single Chinese medical center experience from 2002 to 2012. Zhang Y; Yu H; Li H Int Urol Nephrol; 2015 Aug; 47(8):1327-33. PubMed ID: 26163269 [TBL] [Abstract][Full Text] [Related]
3. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series. Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ; BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519 [TBL] [Abstract][Full Text] [Related]
5. Mortality Increases When Radical Nephrectomy is Delayed More Than 60 Days for T3 Renal Cell Carcinoma. Zhao F; Liu X; Zhang C; Zhu H; Qi N Technol Cancer Res Treat; 2021; 20():15330338211043963. PubMed ID: 34595976 [No Abstract] [Full Text] [Related]
7. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy. Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350 [TBL] [Abstract][Full Text] [Related]
8. Kidney autotransplantation after nephrectomy and work bench surgery as an ultimate approach to nephron-sparing surgery. Janssen MWW; Linxweiler J; Philipps I; Bütow Z; Siemer S; Stöckle M; Ohlmann CH World J Surg Oncol; 2018 Feb; 16(1):35. PubMed ID: 29463251 [TBL] [Abstract][Full Text] [Related]
9. [Long-term survival analysis of 1 367 patients treated with radical nephrectomy from a single center]. Zou XP; Ning K; Zhang ZL; Zou L; Xiong LB; Peng YL; Zhou ZH; Liu HM; Yu CP; Dong P; Guo SJ; Han H; Zhou FJ Zhonghua Zhong Liu Za Zhi; 2023 Nov; 45(11):981-987. PubMed ID: 37968085 [No Abstract] [Full Text] [Related]
10. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC. Waldert M; Haitel A; Marberger M; Katzenbeisser D; Ozsoy M; Stadler E; Remzi M BJU Int; 2008 Nov; 102(10):1381-4. PubMed ID: 18782311 [TBL] [Abstract][Full Text] [Related]
11. Extent of lymph node dissection at nephrectomy affects cancer-specific survival and metastatic progression in specific sub-categories of patients with renal cell carcinoma (RCC). Capitanio U; Suardi N; Matloob R; Roscigno M; Abdollah F; Di Trapani E; Moschini M; Gallina A; Salonia A; Briganti A; Montorsi F; Bertini R BJU Int; 2014 Aug; 114(2):210-5. PubMed ID: 24854206 [TBL] [Abstract][Full Text] [Related]
12. [Clinicopathological features and prognosis of renal cell carcinoma with sarcomatoid differentiation]. Jiang Y; Su G; Yu W; Li J; Lu Q; Li Y; Zhang W Zhonghua Zhong Liu Za Zhi; 2015 Nov; 37(11):823-6. PubMed ID: 26887511 [TBL] [Abstract][Full Text] [Related]
14. Renal fossa recurrence after nephrectomy for renal cell carcinoma: prognostic features and oncological outcomes. Psutka SP; Heidenreich M; Boorjian SA; Bailey GC; Cheville JC; Stewart-Merrill SB; Lohse CM; Atwell TD; Costello BA; Leibovich BC; Thompson RH BJU Int; 2017 Jan; 119(1):116-127. PubMed ID: 27489013 [TBL] [Abstract][Full Text] [Related]
15. The key role of time in predicting progression-free survival in patients with renal cell carcinoma treated with partial or radical nephrectomy: conditional survival analysis. Abdollah F; Suardi N; Capitanio U; Matloob R; Fossati N; Castiglione F; Di Trapani E; Di Trapani D; Russo A; Carenzi C; Montorsi F; Rigatti P; Bertini R Urol Oncol; 2014 Jan; 32(1):43.e9-16. PubMed ID: 23911684 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system. Belldegrun A; Tsui KH; deKernion JB; Smith RB J Clin Oncol; 1999 Sep; 17(9):2868-75. PubMed ID: 10561364 [TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in a large multi-institutional series of papillary renal cell carcinoma. Zucchi A; Novara G; Costantini E; Antonelli A; Carini M; Carmignani G; Cosciani Cunico S; Fontana D; Longo N; Martignoni G; Minervini A; Mirone V; Porena M; Roscigno M; Schiavina R; Simeone C; Simonato A; Siracusano S; Terrone C; Ficarra V BJU Int; 2012 Apr; 109(8):1140-6. PubMed ID: 21871053 [TBL] [Abstract][Full Text] [Related]
18. Impact of histologic subtype and sarcomatoid transformation on metastasis in renal cell carcinoma: a single institute experience in 149 patients. Tirumani SH; Souza D; Krajewski KM; Jagannathan JP; Ramaiya NH; Shinagare AB Abdom Radiol (NY); 2016 Feb; 41(2):295-302. PubMed ID: 26867911 [TBL] [Abstract][Full Text] [Related]
19. Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome. Cheville JC; Lohse CM; Zincke H; Weaver AL; Leibovich BC; Frank I; Blute ML Am J Surg Pathol; 2004 Apr; 28(4):435-41. PubMed ID: 15087662 [TBL] [Abstract][Full Text] [Related]
20. Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection. Gershman B; Moreira DM; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC Eur Urol; 2017 Aug; 72(2):300-306. PubMed ID: 28094055 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]